Literature DB >> 11514576

CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure.

F Coustry1, Q Hu, B de Crombrugghe, S N Maity.   

Abstract

To understand the role of CCAAT-binding factor (CBF) in transcription in the context of chromatin-assembled DNA, we used regularly spaced nucleosomal DNA using topoisomerase IIalpha (topo IIalpha) and alpha2(1) collagen promoter templates, which were subsequently reconstituted in an in vitro transcription reaction. Binding of CBF to the nucleosomal wild-type topo IIalpha promoter containing four CBF-binding sites disrupted the regular nucleosomal structure not only in the promoter region containing the CBF-binding sites but also in the downstream region over the transcription start site. In contrast, no nucleosome disruption was observed in a mutant topo IIalpha promoter containing mutations in all CBF-binding sites. Interestingly, CBF also activated transcription from nucleosomal wild-type topo IIalpha promoter. In this experiment, a promoter containing one wild-type CBF-binding site was activated very weakly, whereas the promoter containing mutations in all sites was not activated by CBF. A truncated CBF that lacked the glutamine-rich domains did not activate transcription from nucleosomal wild-type topo IIalpha promoter but disrupted the nucleosomal structure about as much as did the binding of full-length CBF. Two nucleosomal mouse alpha2(1) collagen promoter DNAs, one containing a single and the other containing four CBF- binding sites, were also reconstituted in an in vitro transcription reaction. None of the nucleosomal collagen promoters was activated by CBF. However, both of these collagen promoters were activated by CBF when the transcription reaction was performed using naked DNA templates. Binding of CBF to the nucleosomal collagen promoter containing four binding sites disrupted the nucleosomal structure, similarly as observed in the topo IIalpha promoter. Altogether this study indicates that CBF-mediated nucleosomal disruption occurred independently of transcription activation. It also suggests that specific promoter structure may play a role in the CBF-mediated transcription activation of nucleosomal topo IIalpha promoter template.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514576     DOI: 10.1074/jbc.M106918200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  DNA compaction by the nuclear factor-Y.

Authors:  Rosalinda F Guerra; Laura Imperadori; Roberto Mantovani; David D Dunlap; Laura Finzi
Journal:  Biophys J       Date:  2007-04-13       Impact factor: 4.033

Review 2.  Mechanisms regulating zygotic genome activation.

Authors:  Katharine N Schulz; Melissa M Harrison
Journal:  Nat Rev Genet       Date:  2019-04       Impact factor: 53.242

3.  Calcium channel blockers act through nuclear factor Y to control transcription of key cardiac genes.

Authors:  Hyunjoo Cha-Molstad; Guanlan Xu; Junqin Chen; Gu Jing; Martin E Young; John C Chatham; Anath Shalev
Journal:  Mol Pharmacol       Date:  2012-06-25       Impact factor: 4.436

4.  Histone-fold domain protein NF-Y promotes chromatin accessibility for cell type-specific master transcription factors.

Authors:  Andrew J Oldfield; Pengyi Yang; Amanda E Conway; Senthilkumar Cinghu; Johannes M Freudenberg; Sailu Yellaboina; Raja Jothi
Journal:  Mol Cell       Date:  2014-08-14       Impact factor: 17.970

5.  Human p32, interacts with B subunit of the CCAAT-binding factor, CBF/NF-Y, and inhibits CBF-mediated transcription activation in vitro.

Authors:  Chandrani Chattopadhyay; David Hawke; Ryuji Kobayashi; Sankar N Maity
Journal:  Nucleic Acids Res       Date:  2004-07-08       Impact factor: 16.971

6.  The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template.

Authors:  Françoise Coustry; Chun-do Oh; Takako Hattori; Sankar N Maity; Benoit de Crombrugghe; Hideyo Yasuda
Journal:  Nucleic Acids Res       Date:  2010-05-19       Impact factor: 16.971

Review 7.  Targeting the Y/CCAAT box in cancer: YB-1 (YBX1) or NF-Y?

Authors:  D Dolfini; R Mantovani
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

8.  Tissue-specific expression patterns of Arabidopsis NF-Y transcription factors suggest potential for extensive combinatorial complexity.

Authors:  Nicholas Siefers; Kristen K Dang; Roderick W Kumimoto; William Edwards Bynum; Gregory Tayrose; Ben F Holt
Journal:  Plant Physiol       Date:  2008-11-19       Impact factor: 8.340

9.  Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.

Authors:  Chun-Nam Lok; Alexander J Lang; Shelagh E L Mirski; Susan P C Cole
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

10.  Inhibition of CBF/NF-Y mediated transcription activation arrests cells at G2/M phase and suppresses expression of genes activated at G2/M phase of the cell cycle.

Authors:  Qianghua Hu; Jing-Fang Lu; Rong Luo; Subrata Sen; Sankar N Maity
Journal:  Nucleic Acids Res       Date:  2006-11-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.